Antiphospholipid antibodies (aPL) are a heterogeneous family of antibo
dies, including those specific for a variety of phospholipid (PL)-bind
ing proteins and also those reacting with PL molecules. The former see
m to be associated with the antiphospholipid syndrome (APS). At presen
t, the main proteins proposed as antigens are beta 2 glycoprotein I, p
rothrombin. protein C, protein S, kininogens and annexin V. Anionic PL
might play a key role ''in vivo'' in the binding of aPL to PL-Sound p
roteins. Different mechanisms may be involved in the pathogenesis of t
he APS, including effects of aPL on the protein C system and antithrom
bin III and also on platelets, endothelial cells and monocytes. Recent
data on experimental animal models have provided support for a causat
ive role of aPL in the clinical complications of the APS.